(-)-epigallocatechin 3-gallate decreases expression ISO RGD:1320510 6480464 epigallocatechin gallate results in decreased expression of ANXA11 protein CTD PMID:31195006 (1->4)-beta-D-glucan multiple interactions ISO RGD:1553345 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ANXA11 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO RGD:1553345 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANXA11 mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1320510 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553345 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA11 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320510 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA11 mRNA CTD PMID:20106945 , PMID:21632981 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ANXA11 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:1320510 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of ANXA11 protein CTD PMID:32044396 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1553345 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ANXA11 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1553345 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ANXA11 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1320510 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA11 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1553345 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA11 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:1553345 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ANXA11 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:1320510 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA11 protein CTD PMID:34186270 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ANXA11 mRNA CTD PMID:24780913 aflatoxin B1 increases methylation ISO RGD:1320510 6480464 Aflatoxin B1 results in increased methylation of ANXA11 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1320510 6480464 Tretinoin results in increased expression of ANXA11 mRNA CTD PMID:16249480 more ... antirheumatic drug increases expression ISO RGD:1320510 6480464 Antirheumatic Agents results in increased expression of ANXA11 mRNA CTD PMID:24449571 arsenous acid multiple interactions ISO RGD:1320510 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANXA11 protein] CTD PMID:26598702 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 benzo[a]pyrene affects methylation ISO RGD:1320510 6480464 Benzo(a)pyrene affects the methylation of ANXA11 3' UTR, Benzo(a)pyrene affects the methylation of ANXA11 5' UTR CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANXA11 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1553345 6480464 bisphenol A results in increased expression of ANXA11 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1320510 6480464 bisphenol A results in decreased expression of ANXA11 protein CTD PMID:31675489 , PMID:34186270 bisphenol A decreases methylation ISO RGD:1320510 6480464 bisphenol A results in decreased methylation of ANXA11 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1320510 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ANXA11 protein CTD PMID:31629898 Bisphenol B increases expression ISO RGD:1320510 6480464 bisphenol B results in increased expression of ANXA11 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1320510 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA11 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1320510 6480464 bisphenol F results in increased expression of ANXA11 protein CTD PMID:34186270 butanal decreases expression ISO RGD:1320510 6480464 butyraldehyde results in decreased expression of ANXA11 mRNA CTD PMID:26079696 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ANXA11 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO RGD:1320510 6480464 Cadmium Chloride results in increased expression of ANXA11 protein CTD PMID:24527689 caffeine decreases expression ISO RGD:1320510 6480464 Caffeine results in decreased expression of ANXA11 protein CTD PMID:31195006 carbamazepine affects expression ISO RGD:1320510 6480464 Carbamazepine affects the expression of ANXA11 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1553345 6480464 Nanotubes, Carbon results in decreased expression of ANXA11 mRNA CTD PMID:25554681 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:1553345 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ANXA11 gene CTD PMID:20938992 cobalt dichloride decreases expression ISO RGD:1320510 6480464 cobaltous chloride results in decreased expression of ANXA11 mRNA CTD PMID:19320972 , PMID:19376846 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ANXA11 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1320510 6480464 Cyclosporine results in decreased expression of ANXA11 mRNA CTD PMID:20106945 decabromodiphenyl ether decreases expression ISO RGD:1320510 6480464 decabromobiphenyl ether results in decreased expression of ANXA11 protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1320510 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA11 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:1320510 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANXA11 protein] CTD PMID:26598702 dibutyl phthalate decreases expression ISO RGD:1553345 6480464 Dibutyl Phthalate results in decreased expression of ANXA11 mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1320510 6480464 dicrotophos results in increased expression of ANXA11 mRNA CTD PMID:28302478 disodium selenite increases expression ISO RGD:1320510 6480464 Sodium Selenite results in increased expression of ANXA11 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1320510 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1320510 6480464 entinostat results in increased expression of ANXA11 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1320510 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANXA11 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:1553345 6480464 epoxiconazole results in decreased expression of ANXA11 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1320510 6480464 Ethanol results in increased expression of ANXA11 mRNA CTD PMID:28986285 ethanol affects expression ISO RGD:1553345 6480464 Ethanol affects the expression of ANXA11 mRNA CTD PMID:30319688 fenthion increases expression ISO RGD:1553345 6480464 Fenthion results in increased expression of ANXA11 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1553345 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 furan increases methylation EXP 6480464 furan results in increased methylation of ANXA11 gene CTD PMID:22079235 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANXA11 mRNA CTD PMID:22061828 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 indometacin multiple interactions ISO RGD:1320510 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANXA11 mRNA CTD PMID:28628672 isobutanol multiple interactions ISO RGD:1320510 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ANXA11 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1320510 6480464 Ivermectin results in decreased expression of ANXA11 protein CTD PMID:32959892 ketamine increases expression EXP 6480464 Ketamine results in increased expression of ANXA11 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:1553345 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ANXA11 gene CTD PMID:20938992 lithium chloride increases expression ISO RGD:1320510 6480464 Lithium Chloride results in increased expression of ANXA11 mRNA CTD PMID:23527032 methidathion increases expression ISO RGD:1553345 6480464 methidathion results in increased expression of ANXA11 mRNA CTD PMID:34813904 methotrexate affects response to substance ISO RGD:1320510 6480464 ANXA11 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride decreases expression ISO RGD:1320510 6480464 methylmercuric chloride results in decreased expression of ANXA11 mRNA CTD PMID:23179753 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ANXA11 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO RGD:1320510 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANXA11 mRNA CTD PMID:24810058 nickel atom decreases expression ISO RGD:1320510 6480464 Nickel results in decreased expression of ANXA11 mRNA CTD PMID:24768652 , PMID:25583101 paracetamol decreases expression ISO RGD:1320510 6480464 Acetaminophen results in decreased expression of ANXA11 mRNA CTD PMID:21420995 pentanal decreases expression ISO RGD:1320510 6480464 pentanal results in decreased expression of ANXA11 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1553345 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ANXA11 mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of ANXA11 gene CTD PMID:33148267 phenol red multiple interactions ISO RGD:1320510 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ANXA11 protein CTD PMID:31629898 phenylmercury acetate increases expression ISO RGD:1320510 6480464 Phenylmercuric Acetate results in increased expression of ANXA11 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1320510 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA11 mRNA CTD PMID:27188386 propanal decreases expression ISO RGD:1320510 6480464 propionaldehyde results in decreased expression of ANXA11 mRNA CTD PMID:26079696 resveratrol decreases expression ISO RGD:1320510 6480464 resveratrol results in decreased expression of ANXA11 protein CTD PMID:18089832 SB 431542 multiple interactions ISO RGD:1320510 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA CTD PMID:33854195 trichostatin A increases expression ISO RGD:1320510 6480464 trichostatin A results in increased expression of ANXA11 mRNA CTD PMID:24935251 troglitazone decreases expression ISO RGD:1553345 6480464 troglitazone results in decreased expression of ANXA11 mRNA CTD PMID:28973697 valproic acid increases expression ISO RGD:1553345 6480464 Valproic Acid results in increased expression of ANXA11 mRNA CTD PMID:15345369 valproic acid increases expression ISO RGD:1320510 6480464 Valproic Acid results in increased expression of ANXA11 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1320510 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA11 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:1320510 6480464 Valproic Acid affects the expression of ANXA11 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ANXA11 mRNA CTD PMID:22570695